vxa101

Vitali Alexeev, PhD

Contact Dr. Alexeev

233 S. 10th Street
Room 319
Philadelphia, PA 19107

(215) 503-4835

Most Recent Peer-reviewed Publications

  1. Misbalanced CXCL12 and CCL5 Chemotactic Signals in Vitiligo Onset and Progression
  2. Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment
  3. Chemotaxis-driven disease-site targeting of therapeutic adult stem cells in dystrophic epidermolysis bullosa
  4. Reaction Chemistry Generated by Nanosecond Pulsed Dielectric Barrier Discharge Treatment is Responsible for the Tumor Eradication in the B16 Melanoma Mouse Model
  5. Fibulin-4 E57K knock-in mice recapitulate cutaneous, vascular and skeletal defects of recessive cutis laxa 1B with both elastic fiber and collagen fibril abnormalities
  6. The triterpenoid RTA 408 is a robust mitigator of hematopoietic acute radiation syndrome in mice
  7. Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells
  8. Radiation protection of the gastrointestinal tract and growth inhibition of prostate cancer xenografts by a single compound
  9. Human adipose-derived stem cell transplantation as a potential therapy for collagen VI-related congenital muscular dystrophy
  10. Chemokine-enhanced DNA vaccination in cancer immunotherapy
  11. Immunotargeting and eradication of orthotopic melanoma using a chemokine-enhanced DNA vaccine
  12. Analysis of chemotactic molecules in bone marrow-derived mesenchymal stem cells and the skin: Ccl27-Ccr10 axis as a basis for targeting to cutaneous tissues
  13. Interleukin 10 in the tumor microenvironment: A target for anticancer immunotherapy
  14. Gene expression signatures of mouse bone marrow-derived mesenchymal stem cells in the cutaneous environment and therapeutic implications for blistering skin disorder
  15. Targeted manipulation of mammalian genomes using designed zinc finger nucleases
  16. Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: Immunoadhesins for human IL-10 with therapeutic potential
  17. Retroviral delivery of ECM genes.
  18. MicroRNA-dependent regulation of cKit in cutaneous melanoma
  19. Site-specific gene modification by oligodeoxynucleotides in mouse bone marrow-derived mesenchymal stem cells
  20. Protein therapeutics for junctional epidermolysis bullosa: Incorporation of recombinant ╬▓3 chain into laminin 332 in ╬▓3-/- keratinocytes in vitro